CTRI/2021/12/039024尚未招募4 期
A Multicentric, non-randomized, open label, non-comparative, active post marketingsurveillance (PMS) to evaluate the safety and efficacy of Wikoryl Oral Drops in infants sufferingfrom Common cold with fever
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Pms
入排标准
入选标准
- •1. Age: up to 1 year (weight: 2.5-12 kg)
- •2. Genders Eligible for Study: both Males and Females
- •3. Patients with confirmed clinical diagnosis of Common cold with fever
- •4. Patients whose guardians can adhere to the Protocol
排除标准
- •1. Patients known to be hypersensitive to investigational product
- •2. Patients with severe hepatic or renal dysfunction
研究者
相似试验
已完成
4 期
Active post marketing surveillance (PMS) to evaluate the safety and efficacy of Sinarest Oral Drops in infants of common cold or allergic rhinitis.CTRI/2021/11/037913Centaur Pharmaceuticals Pvt Ltd415
已完成
4 期
Active post marketing surveillance to evaluate the safety and efficacy of Sinarest Syrup in children of common cold or allergic rhinitis.CTRI/2021/11/037912Centaur Pharmaceuticals Pvt Ltd417
尚未招募
4 期
Post marketing study to assess the Safety and Efficacy of Wikoryl 10 tablets in adults suffering from common coldCTRI/2022/03/041002Alembic Pharmaceuticals Limited
已完成
4 期
Active post marketing surveillance to evaluate the Safety and Efficacy of Sinarest Plus Suspension in children of common cold or allergic rhinitis.CTRI/2021/11/037910Centaur Pharmaceuticals Pvt Ltd420
已完成
4 期
Active post marketing surveillance to evaluate the Safety and Efficacy of Sinarest New Tablet in adults of common cold or allergic rhinitis.CTRI/2021/11/037857Centaur Pharmaceuticals Pvt Ltd420